Ionis raises ~$500M in public offering of 11.5M shares at $43.50/share

IONIS PHARMACEUTICALS INC

Sold 11.5M shares of common stock at $43.50 per share; gross proceeds ~$500.3M.
Underwriters have 30-day option to purchase up to an additional 1.725M shares.
Offering closed September 11, 2024; lead underwriters Morgan Stanley and Goldman Sachs.
Proceeds not specified; offering conducted under existing shelf registration.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.